Perfluoroalkyl substances and changes in bone mineral density: A prospective analysis in the POUNDS-LOST study
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Background Recent studies suggested an inverse association between exposures to perfluoroalkyl substances (PFASs) and bone mineral density (BMD). Whether exposures to PFASs are also associated with changes in BMD has not been examined. Methods Five major PFASs (perfluorooctanesulfonic acid, PFOS; perfluorooctanoic acid, PFOA; perfluorohexanesulfonic acid, PFHxS; perfluorononanoic acid, PFNA; perfluorodecanoic acid, PFDA) and BMD (g/cm2) at six bone sites (spine, total hip, femoral neck, hip intertrochanteric area, hip trochanter, and hip Ward’s triangle area) were measured at baseline among 294 participants in the POUNDS-LOST study, a weight-loss trial, of whom a total of 175 participants had BMD measured at both baseline and year 2. Linear regression was used to model the differences or changes in BMD for each SD increment of PFAS concentrations. In a secondary analysis, interactions between PFASs and baseline body mass index (BMI), as well as a BMI-related genetic risk score (GRS) derived from 97 BMI-predicting SNPs were examined in relation to changes in BMD. Results At baseline, both PFOS and PFOA were significantly associated with lower BMD at several sites. For each SD increase of PFOS, the β s (95% CIs) for BMD were −0.020(−0.037, −0.003) for spine, −0.013(−0.026, 0.001) for total hip, −0.014(−0.028, 0.000) for femoral neck, and −0.013(−0.026, 0.000) for hip trochanter. For PFOA, the corresponding figures were −0.021(−0.038, −0.004) for spine, −0.015(−0.029, −0.001) for total hip, and −0.015(−0.029, −0.002) for femoral neck. After adjusting for baseline covariates and 2-year weight change, higher baseline plasma concentrations of PFOS, PFNA, and PFDA were associated with greater reduction in BMD in the hip; the βs (95% CIs) were −0.005(−0.009, −0.001), −0.006(−0.010, −0.001), and −0.005(−0.009, −0.001), respectively. Similar associations were found in hip intertrochanteric area for all PFASs except PFHxS, with βs ranging from −0.006 for PFOA to −0.008 for PFOS and PFNA. Participants with a higher GRS tended to have less PFAS-related BMD decline in total hip (Pinteraction = 0.005) and the hip intertrochanteric area (Pinteraction = 0.021). There were similar PFAS-related BMD changes by baseline BMI levels, although the interactions did not achieve statistical significance. Conclusions This study demonstrated that higher plasma PFAS concentrations were not only associated with a lower BMD at baseline, but also a faster BMD loss in a weight-loss trial setting. Genetic predisposition to larger body size may somewhat attenuate the deleterious effects of PFASs on BMD. Further exploration of the possible impact of PFAS exposures on bone density is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates
Sacks, F. M., Bray, G. A., Carey, V. J., Smith, S. R., Ryan, D. H., Anton, S. D., McManus, K., Champagne, C. M., Bishop, L. M., Laranjo, N., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804748 · Cited by 1,966 · cited 1×
“Detailed description of the trial design has been published elsewhere (Sacks et al., 2009; Williamson et al., 2010).”
BackgroundSelf-citationPolyfluorinated Compounds: Past, Present, and Future
Lindstrom, A. B., Strynar, M. J., & Libelo, E. L. (2011) · Environmental Science & Technology · doi:10.1021/es2011622 · Cited by 1,628 · cited 2×
“The persistence of PFASs in the environment and human body makes these chemicals a long-term health concern (Lindstrom et al., 2011).”
BackgroundTrends in Exposure to Polyfluoroalkyl Chemicals in the U.S. Population: 1999−2008
Kato, K., Wong, L.-Y., Jia, L. T., Kuklenyik, Z., & Calafat, A. M. (2011) · Environmental Science & Technology · doi:10.1021/es1043613 · Cited by 777
The molecular actions of thyroid hormone in bone
Duncan Bassett, J. H., & Williams, G. R. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(03)00144-9 · Cited by 261 · cited 1×
“, 2016), which are essential for the normal development of endochondral and intramembranous bone and play an important role in the linear growth and maintenance of bone mass (Bassett and Williams, 2003).”
Backgroundde Souza, R. J., Bray, G. A., Carey, V. J., Hall, K. D., LeBoff, M. S., Loria, C. M., Laranjo, N. M., Sacks, F. M., & Smith, S. R. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.026328 · Cited by 192
Self-citationThyroid Hormone Use and Bone Mineral Density in Elderly Women: Effects of Estrogen
Schneider, D. L. (1994) · JAMA · doi:10.1001/jama.271.16.1245 · Cited by 157
Post, G. B., Gleason, J. A., & Cooper, K. R. (2017) · PLOS Biology · doi:10.1371/journal.pbio.2002855 · Cited by 145 · cited 2×
“Few mechanistic studies have been conducted to specifically elucidate the role of PFASs on bone health, although current evidence from animal models suggests that PFASs may influence BMD through their adverse effects via modulating hormone functions (Post et al., 2017), e.”
BackgroundPerfluoroalkyl substances and thyroid function in older adults
Shrestha, S., Bloom, M. S., Yucel, R., Seegal, R. F., Wu, Q., Kannan, K., Rej, R., & Fitzgerald, E. F. (2015) · Environment International · doi:10.1016/j.envint.2014.11.018 · Cited by 76
Adherence is a multi-dimensional construct in the POUNDS LOST trial
Williamson, D. A., Anton, S. D., Han, H., Champagne, C. M., Allen, R., LeBlanc, E., Ryan, D. H., McManus, K., Laranjo, N., Carey, V. J., et al. (2010) · Journal of Behavioral Medicine · doi:10.1007/s10865-009-9230-7 · Cited by 58 · cited 1×
“Detailed description of the trial design has been published elsewhere (Sacks et al., 2009; Williamson et al., 2010).”
Background
Cited by
Fenton, S. E., Ducatman, A., Boobis, A., DeWitt, J. C., Lau, C., Ng, C., Smith, J. S., & Roberts, S. M. (2020) · Environmental Toxicology and Chemistry · doi:10.1002/etc.4890 · Cited by 2,445
Brase, R. A., Mullin, E. J., & Spink, D. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22030995 · Cited by 374
Environmental impacts, exposure pathways, and health effects of PFOA and PFOS
Wee, S. Y., & Aris, A. Z. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115663 · Cited by 275
Exposure to environmental chemicals and human bone health; A systematic review and meta-analysis
Baradaran Mahdavi, S., Zamani, S., Riahi, R., Taheri, E., Vahdatpour, B., Sharifianjazi, F., & Kelishadi, R. (2024) · Exposure and Health · doi:10.1007/s12403-023-00596-3 · Cited by 16
“…studies (Buckley et al. 2021; Jeddy et al. 2018), one cross-sectional analysis on the participants of a prospective study (Cluett et al. 2019), one cohort study with both cross-sectional and prospective analyses (Hu et al. 2019) and two cross-sectional studies (Khalil et al. 2016; Lin et al. 2014).”
Influential
Metadata
- Authors
- Hu, Y., Liu, G., Rood, J., Liang, L., Bray, G. A., de Jonge, L., Coull, B., Furtado, J. D., Qi, L., Grandjean, P., & Sun, Q.
- Venue
- Environmental Research
- Publisher
- Elsevier BV
- Published
- 2019-12
- Volume
- 179
- Issue
- Pt A
- Pages
- 108775
- ISSN
- 0013-9351 (ISSN-L)
- OpenAlex
- W2976189361
- Cited by
- 47
- References
- 9
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.